FOSB and eosinophilic esophagitis: As a feature in these pathways, we observe modest upregulation in FOSB (fold change 1.68, FDR = 0.042), suggesting that altered expression of the AP‐1 transcription factor in peripheral T cells may be a potential mechanism of action of EPIT therapy in EoE patients.